Global Mildronate Dihydrate Market Insights, Research, Forecast to 2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 114

Report ID: 9072

Mildronate is a registered trademark of the Grindex. Its active substance is meldonium. Meldonium is a limited-market pharmaceutical, and is an ‘anti-ischemic’ drug, which means it is used to treat inadequate blood-flow to the organs, especially the heart. It is primarily used to treat patients with heart conditions that affect the body’s ability to deliver oxygen to the body. It helps to protect against tissue damage from angina attacks, chronic heart failure and disorders of brain circulation.
Mildronate dihydrate production has high technology barrier and is technology intensive industry. Currently, there are several producing companies in the Europe mildronate dihydrate industry. The main market player is Grindeks.
Mildronate dihydrate mainly has three existence forms, which include mildronate dihydrate capsule, mildronate dihydrate injection and mildronate dihydrate tablet. With medical effect of mildronate dihydrate, the downstream application industries will need more mildronate dihydrate products. So far, it isn't approved by the FDA in the United States.
The major raw materials for mildronate dihydrate are tert-Butyl acrylate (TBA), unsymmetrical dimethylhydrazine (UDMH) and ethanol, etc. Fluctuations in the price of the upstream product will impact on the production cost of mildronate dihydrate, and then impact the price of mildronate dihydrate. The production cost of mildronate dihydrate is also an important factor which could impact the price of mildronate dihydrate. The mildronate dihydrate manufacturers are trying to reduce production cost by developing production method.
The global Mildronate Dihydrate market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Mildronate Dihydrate market based on company, product type, end user and key regions.

This report studies the global market size of Mildronate Dihydrate in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Mildronate Dihydrate in these regions.
This research report categorizes the global Mildronate Dihydrate market by top players/brands, region, type and end user. This report also studies the global Mildronate Dihydrate market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Grindeks

Market size by Product
Capsule
Injection
Tablet
Market size by End User
Cardiovascular Disease
Other

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Mildronate Dihydrate market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Mildronate Dihydrate market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Mildronate Dihydrate companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Mildronate Dihydrate submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Mildronate Dihydrate are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Mildronate Dihydrate market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Mildronate Dihydrate Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Mildronate Dihydrate Market Size Growth Rate by Product
1.4.2 Capsule
1.4.3 Injection
1.4.4 Tablet
1.5 Market by End User
1.5.1 Global Mildronate Dihydrate Market Size Growth Rate by End User
1.5.2 Cardiovascular Disease
1.5.3 Other
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Mildronate Dihydrate Market Size
2.1.1 Global Mildronate Dihydrate Revenue 2014-2025
2.1.2 Global Mildronate Dihydrate Sales 2014-2025
2.2 Mildronate Dihydrate Growth Rate by Regions
2.2.1 Global Mildronate Dihydrate Sales by Regions
2.2.2 Global Mildronate Dihydrate Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Mildronate Dihydrate Sales by Manufacturers
3.1.1 Mildronate Dihydrate Sales by Manufacturers
3.1.2 Mildronate Dihydrate Sales Market Share by Manufacturers
3.1.3 Global Mildronate Dihydrate Market Concentration Ratio (CR5 and HHI)
3.2 Mildronate Dihydrate Revenue by Manufacturers
3.2.1 Mildronate Dihydrate Revenue by Manufacturers (2014-2019)
3.2.2 Mildronate Dihydrate Revenue Share by Manufacturers (2014-2019)
3.3 Mildronate Dihydrate Price by Manufacturers
3.4 Mildronate Dihydrate Manufacturing Base Distribution, Product Types
3.4.1 Mildronate Dihydrate Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Mildronate Dihydrate Product Type
3.4.3 Date of International Manufacturers Enter into Mildronate Dihydrate Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Mildronate Dihydrate Sales by Product
4.2 Global Mildronate Dihydrate Revenue by Product
4.3 Mildronate Dihydrate Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Mildronate Dihydrate Breakdown Data by End User

6 North America
6.1 North America Mildronate Dihydrate by Countries
6.1.1 North America Mildronate Dihydrate Sales by Countries
6.1.2 North America Mildronate Dihydrate Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Mildronate Dihydrate by Product
6.3 North America Mildronate Dihydrate by End User

7 Europe
7.1 Europe Mildronate Dihydrate by Countries
7.1.1 Europe Mildronate Dihydrate Sales by Countries
7.1.2 Europe Mildronate Dihydrate Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Mildronate Dihydrate by Product
7.3 Europe Mildronate Dihydrate by End User

8 Asia Pacific
8.1 Asia Pacific Mildronate Dihydrate by Countries
8.1.1 Asia Pacific Mildronate Dihydrate Sales by Countries
8.1.2 Asia Pacific Mildronate Dihydrate Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Mildronate Dihydrate by Product
8.3 Asia Pacific Mildronate Dihydrate by End User

9 Central & South America
9.1 Central & South America Mildronate Dihydrate by Countries
9.1.1 Central & South America Mildronate Dihydrate Sales by Countries
9.1.2 Central & South America Mildronate Dihydrate Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Mildronate Dihydrate by Product
9.3 Central & South America Mildronate Dihydrate by End User

10 Middle East and Africa
10.1 Middle East and Africa Mildronate Dihydrate by Countries
10.1.1 Middle East and Africa Mildronate Dihydrate Sales by Countries
10.1.2 Middle East and Africa Mildronate Dihydrate Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Mildronate Dihydrate by Product
10.3 Middle East and Africa Mildronate Dihydrate by End User

11 Company Profiles
11.1 Grindeks
11.1.1 Grindeks Company Details
11.1.2 Company Business Overview
11.1.3 Grindeks Mildronate Dihydrate Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Grindeks Mildronate Dihydrate Products Offered
11.1.5 Grindeks Recent Development

12 Future Forecast
12.1 Mildronate Dihydrate Market Forecast by Regions
12.1.1 Global Mildronate Dihydrate Sales Forecast by Regions 2019-2025
12.1.2 Global Mildronate Dihydrate Revenue Forecast by Regions 2019-2025
12.2 Mildronate Dihydrate Market Forecast by Product
12.2.1 Global Mildronate Dihydrate Sales Forecast by Product 2019-2025
12.2.2 Global Mildronate Dihydrate Revenue Forecast by Product 2019-2025
12.3 Mildronate Dihydrate Market Forecast by End User
12.4 North America Mildronate Dihydrate Forecast
12.5 Europe Mildronate Dihydrate Forecast
12.6 Asia Pacific Mildronate Dihydrate Forecast
12.7 Central & South America Mildronate Dihydrate Forecast
12.8 Middle East and Africa Mildronate Dihydrate Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Mildronate Dihydrate Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer